Pseudohyperglycemia due to glucometer interference in galactosemia

Clin Chem Lab Med. 2023 Nov 30;62(5):e107-e109. doi: 10.1515/cclm-2023-1304. Print 2024 Apr 25.

Bram Decru¹, Hilde Blanckaert², Gunnar Naulaers^{3

4}, Christine Vanhole⁴, Daisy Rymen^{5

6}, Peter Witters^{5

6}, Inge Van Wambeke⁷, Pieter Gillard⁸, Pieter Vermeersch^{1

9}

¹ Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
² Department of Laboratory Medicine, Heilig Hart Hospital, Leuven, Belgium.
³ Neonatal Intensive Care, University Hospitals Leuven, Leuven, Belgium.
⁴ Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
⁵ Department of Development and Regeneration, University of Leuven, Leuven, Belgium.
⁶ Department of Pediatrics, Center for Metabolic Diseases, University Hospitals Leuven, Leuven, Belgium.
⁷ Department of Pediatrics, Heilig Hart Hospital, Leuven, Belgium.
⁸ Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium.
⁹ Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.

No abstract available

Keywords: point-of-care-testing; GDH-PQQ; galactosemia; glucose monitoring; infant; pseudohyperglycemia.

Publication types